Literature DB >> 19033108

[Toxicity of cationic liposome Lipofectamine 2000 in human pancreatic cancer Capan-2 cells].

Ying-Qiang Zhong1, Jing Wei, Yu-Ru Fu, Jing Shao, Yi-Wen Liang, Yan-Hua Lin, Juan Liu, Zhao-Hua Zhu.   

Abstract

OBJECTIVE: To investigate the toxicity of cationic liposome Lipofectamine 2000 (Lipo) in human pancreatic cancer Capan-2 cells.
METHODS: Capan-2 cells were cultured in the presence of Lipo at toxic concentrations, and the cell growth, apoptosis and cell cycle changes were evaluated by cell counting and flow cytometry.
RESULTS: The concentrations of both Lipo and siRNA affected the transfection efficiency. In a transfection volume of 2 ml, the presence of 5 microl Lipo resulted in slowed growth of Capan-2 cells, which was especially obvious after 3 days (P<0.001). Prolonged culture of the transfected cells caused significant increases in early apoptotic cells (P<0.05) and in the damaged or necrotic cells (P<0.001), and resulted in reduced viable cells (P<0.01); these changes became obvious after a 48-hour culture, which also increased the ratio of G(0)/G(1) phase cells (P<0.05) and decreased those of G(2)/M phase cells (P<0.01), S phase cells (P<0.01), and the late apoptotic cells (P<0.05).
CONCLUSION: Toxic concentrations of Lipo can affect the growth, apoptosis and cell cycles of Capan-2 cells in vitro, and this urges careful concentration selection when using Lipo for gene transfer into different cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033108

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  8 in total

Review 1.  Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer.

Authors:  Daniel C Julien; Steven Behnke; Guankui Wang; Gordon K Murdoch; Rodney A Hill
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

2.  Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro.

Authors:  Amber M Paul; Yongliang Shi; Dhiraj Acharya; Jessica R Douglas; Amanda Cooley; John F Anderson; Faqing Huang; Fengwei Bai
Journal:  J Gen Virol       Date:  2014-05-14       Impact factor: 3.891

3.  Expression of Drosophila Matrix Metalloproteinases in Cultured Cell Lines Alters Neural and Glial Cell Morphology.

Authors:  Scoty Hearst; Andrea Bednářová; Benjamin Draughn; Kennadi Johnson; Desiree Mills; Cendonia Thomas; Jendaya Scales; Eadie T Keenan; Jewellian V Welcher; Natraj Krishnan
Journal:  Front Cell Dev Biol       Date:  2021-05-13

4.  Highly efficient siRNA transfection in macrophages using apoptotic body-mimic Ca-PS lipopolyplex.

Authors:  Yueyang Lai; Xuebo Xu; Zhenyu Zhu; Zichun Hua
Journal:  Int J Nanomedicine       Date:  2018-10-24

5.  Latency-Associated Transcript-Derived MicroRNAs in Herpes Simplex Virus Type 1 Target SMAD3 and SMAD4 in TGF-β/Smad Signaling Pathway.

Authors:  Zahra Shojaei Jeshvaghani; Ehsan Arefian; Sara Asgharpour; Masoud Soleimani
Journal:  Iran Biomed J       Date:  2021-05-01

6.  Chitosan-Crosslinked Low Molecular Weight PEI-Conjugated Iron Oxide Nanoparticle for Safe and Effective DNA Delivery to Breast Cancer Cells.

Authors:  Guanyou Lin; Jianxi Huang; Mengyuan Zhang; Shanshan Chen; Miqin Zhang
Journal:  Nanomaterials (Basel)       Date:  2022-02-09       Impact factor: 5.076

7.  Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides.

Authors:  Jeremy P Bost; Miina Ojansivu; Michael J Munson; Emelie Wesén; Audrey Gallud; Dhanu Gupta; Oskar Gustafsson; Osama Saher; Julia Rädler; Stuart G Higgins; Taavi Lehto; Margaret N Holme; Anders Dahlén; Ola Engkvist; Per-Erik Strömstedt; Shalini Andersson; C I Edvard Smith; Molly M Stevens; Elin K Esbjörner; Anna Collén; Samir El Andaloussi
Journal:  Commun Biol       Date:  2022-03-01

Review 8.  Hybridizing clinical translatability with enzyme-free DNA signal amplifiers: recent advances in nucleic acid detection and imaging.

Authors:  Raina M Borum; Jesse V Jokerst
Journal:  Biomater Sci       Date:  2020-07-31       Impact factor: 6.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.